Released: 04/10/2020 Expires: 10/31/2021 (subject to change)
CE for this activity will not be available after this date.
Overview According to the Centers for Disease Control and Prevention (CDC), clinicians in the United States wrote 259 million prescriptions for pain medications in 2012, with approximately 4% of US adults taking chronic opioid therapy, mainly for noncancer pain. Opiate analgesics are increasingly being recommended to patients to alleviate severe acute and chronic, moderate-to-severe noncancer pain. Opioid-induced constipation (OIC) is the most common opioid-related adverse effect, affecting up to 70% of patients on long-term opioid therapy. OIC also has a significant impact on patient quality of life (QoL). Patients with OIC experience reduced work productivity, limitations on activities of daily living and social interactions, reductions in dietary choices, impairment of pain management, and greater healthcare resource utilization. This activity will help NPs navigate this complex environment to make the best evidence-based treatment options for their patients. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the posttest
Submit the evaluation to receive full AANP CE/Rx credit.
Objectives • Describe the pathogenesis of opioids in constipation • Identify validated assessment tools used to recognize and evaluate opioid-induced constipation (OIC) • Choose appropriate motivational interviewing strategies to improve patient-clinician communication about OIC symptoms • Select appropriate treatments based on most recent guidelines and individual patient needs Speakers Vicki Morton, DNP, AGNP-BC Disclosure This program was planned in accordance with AANP CE Standards and Policies. Dr. Vicki Morton has no relevant affiliations to disclose. AANP planners have no relevant financial relationships to disclose. Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.75 of which may be applied towards Pharmacology